Study: NCT02992106

Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: We will determine the following biochemical parameters: glucose, insulin, total cholesterol, LDL, HDL, triglycerides, uric acid, IGF-1, adiponectin, leptin, hs-CRP, IL-6, TNF-α and ICAM-1.

Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: We will determine the following biochemical parameters: glucose, insulin, total cholesterol, LDL, HDL, triglycerides, uric acid, IGF-1, adiponectin, leptin, hs-CRP, IL-6, TNF-α and ICAM-1.

Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: We will determine the following biochemical parameters: glucose, insulin, total cholesterol, LDL, HDL, triglycerides, uric acid, IGF-1, adiponectin, leptin, hs-CRP, IL-6, TNF-α and ICAM-1.

Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: We will determine the following biochemical parameters: glucose, insulin, total cholesterol, LDL, HDL, triglycerides, uric acid, IGF-1, adiponectin, leptin, hs-CRP, IL-6, TNF-α and ICAM-1.

Intervention type: OTHER
Group type: OTHER
Intervention: Urine sample
Description: We will take a urine sample to evaluate the albumin to creatinin ratio.

Intervention type: OTHER
Group type: OTHER
Intervention: Urine sample
Description: We will take a urine sample to evaluate the albumin to creatinin ratio.

Intervention type: OTHER
Group type: OTHER
Intervention: Urine sample
Description: We will take a urine sample to evaluate the albumin to creatinin ratio.

Intervention type: OTHER
Group type: OTHER
Intervention: Urine sample
Description: We will take a urine sample to evaluate the albumin to creatinin ratio.

Intervention type: OTHER
Group type: OTHER
Intervention: Anthropometric measurements
Description: We will measure weight, Height, hip, waist and neck circumference, blood pressure, 4-site skinfold measurements and BIA.

Intervention type: OTHER
Group type: OTHER
Intervention: Anthropometric measurements
Description: We will measure weight, Height, hip, waist and neck circumference, blood pressure, 4-site skinfold measurements and BIA.

Intervention type: OTHER
Group type: OTHER
Intervention: Anthropometric measurements
Description: We will measure weight, Height, hip, waist and neck circumference, blood pressure, 4-site skinfold measurements and BIA.

Intervention type: OTHER
Group type: OTHER
Intervention: Anthropometric measurements
Description: We will measure weight, Height, hip, waist and neck circumference, blood pressure, 4-site skinfold measurements and BIA.

Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound
Description: We will do an abdominal ultrasound to measure the abdominal fat accumulation

Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound
Description: We will do an abdominal ultrasound to measure the abdominal fat accumulation

Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound
Description: We will do an abdominal ultrasound to measure the abdominal fat accumulation

Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound
Description: We will do an abdominal ultrasound to measure the abdominal fat accumulation

Intervention type: OTHER
Group type: OTHER
Intervention: EndoPAT
Description: We will use the EndoPAT device to measure endothelial function, which is a non-invasive and innovative technique (peripheral pulse wave amplitude measurement).

Intervention type: OTHER
Group type: OTHER
Intervention: EndoPAT
Description: We will use the EndoPAT device to measure endothelial function, which is a non-invasive and innovative technique (peripheral pulse wave amplitude measurement).

Intervention type: OTHER
Group type: OTHER
Intervention: EndoPAT
Description: We will use the EndoPAT device to measure endothelial function, which is a non-invasive and innovative technique (peripheral pulse wave amplitude measurement).

Intervention type: OTHER
Group type: OTHER
Intervention: EndoPAT
Description: We will use the EndoPAT device to measure endothelial function, which is a non-invasive and innovative technique (peripheral pulse wave amplitude measurement).

Intervention type: OTHER
Group type: OTHER
Intervention: Faces Pain Scale
Description: After performing the measurements with the EndoPAT device, Harpender kalliper and ultrasound, the children will be asked to fill out a Faces Pain Scale, validated for children aged 4-16 years old and obtained for use from the International Association for the Study of Pain

Intervention type: OTHER
Group type: OTHER
Intervention: Faces Pain Scale
Description: After performing the measurements with the EndoPAT device, Harpender kalliper and ultrasound, the children will be asked to fill out a Faces Pain Scale, validated for children aged 4-16 years old and obtained for use from the International Association for the Study of Pain

Intervention type: OTHER
Group type: OTHER
Intervention: Faces Pain Scale
Description: After performing the measurements with the EndoPAT device, Harpender kalliper and ultrasound, the children will be asked to fill out a Faces Pain Scale, validated for children aged 4-16 years old and obtained for use from the International Association for the Study of Pain

Intervention type: OTHER
Group type: OTHER
Intervention: Faces Pain Scale
Description: After performing the measurements with the EndoPAT device, Harpender kalliper and ultrasound, the children will be asked to fill out a Faces Pain Scale, validated for children aged 4-16 years old and obtained for use from the International Association for the Study of Pain